Center for Quality of Care Research, Baystate Medical Center, Springfield, MA, USA.
Crit Care Med. 2012 Mar;40(3):754-61. doi: 10.1097/CCM.0b013e318232db65.
To assess trends in number of hospitalizations, outcomes, and costs of severe sepsis in the United States.
Temporal trends study using the Nationwide Inpatient Sample.
Adult patients with severe sepsis (defined as a diagnosis of sepsis and organ dysfunction) diagnosed between 2003 and 2007.
We determined the weighted frequency of patients hospitalized with severe sepsis. We calculated age- and sex-adjusted population-based mortality rates for severe sepsis per 100,000 population and also used logistic regression to adjust in-hospital mortality rates for patient characteristics. We calculated inflation-adjusted costs using hospital-specific cost-to-charge ratios. We identified a rapid steady increase in the number of cases of severe sepsis, from 415,280 in 2003 to 711,736 in 2007 (a 71% increase). The total hospital costs for all patients with severe sepsis increased from $15.4 billion in 2003 to $24.3 billion in 2007 (57% increase). The proportion of patients with severe sepsis and only a single organ dysfunction decreased from 51% in 2003 to 45% in 2007 (p < .001), whereas the proportion of patients with three or four or more organ dysfunctions increased 1.19-fold and 1.51-fold, respectively (p < .001). During the same time period, we observed 2% decrease per year in hospital mortality for patients with severe sepsis (p < .001), as well as a slight decrease in the length of stay (9.9 days to 9.2 days; p < .001) and a significant decrease in the geometric mean cost per case of severe sepsis ($20,210 per case in 2003 and $19,330 in 2007; p = .025).
The increase in the number of hospitalizations for severe sepsis coupled with declining in-hospital mortality and declining geometric mean cost per case may reflect improvements in care or increases in discharges to skilled nursing facilities; however, these findings more likely represent changes in documentation and hospital coding practices that could bias efforts to conduct national surveillance.
评估美国严重脓毒症住院人数、结局和费用的变化趋势。
使用全国住院患者样本进行时间趋势研究。
2003 年至 2007 年期间诊断为严重脓毒症(定义为脓毒症和器官功能障碍的诊断)的成年患者。
我们确定了严重脓毒症住院患者的加权频率。我们计算了每 10 万人中严重脓毒症的年龄和性别调整后人群死亡率,并使用逻辑回归调整了患者特征的住院死亡率。我们使用医院特定的成本与收费比率计算了通货膨胀调整后的费用。我们发现严重脓毒症病例数迅速稳定增加,从 2003 年的 415280 例增加到 2007 年的 711736 例(增加了 71%)。所有严重脓毒症患者的总住院费用从 2003 年的 154 亿美元增加到 2007 年的 243 亿美元(增加了 57%)。只有单个器官功能障碍的严重脓毒症患者比例从 2003 年的 51%下降到 2007 年的 45%(p<0.001),而三个或四个或更多器官功能障碍的患者比例分别增加了 1.19 倍和 1.51 倍(p<0.001)。在此期间,我们观察到严重脓毒症患者的住院死亡率每年下降 2%(p<0.001),住院时间略有缩短(从 9.9 天缩短至 9.2 天;p<0.001),每个严重脓毒症病例的几何平均费用显著降低(2003 年为 20210 美元,2007 年为 19330 美元;p=0.025)。
严重脓毒症住院人数的增加,加上住院死亡率的下降和每个病例的几何平均费用的下降,可能反映了治疗的改善或向熟练护理机构的出院人数增加;然而,这些发现更可能代表了文档和医院编码实践的变化,这可能会影响国家监测工作。